A Study of BL-B01D1 and BL-B01D1 in Combination With Osimertinib Mesylate Tablets in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer
Clinical trial NCT05880706 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05880706
- Sponsor
- Sichuan Baili Pharmaceutical Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-19
- Primary completion
- 2027-07-01
- Enrollment
- 198
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.